BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September

Day

• 1
• 2
• 3
• 4

• Press Releases

  ONWARD Medical to Announce First-Half 2026 Results on September 9, 2026

  September 4, 2026

   · 

  3 min read
• Press Releases

  Capital Increase in Bavarian Nordic A/S as a Result of Employee Warrant Exercise - September 4, 2026

  September 4, 2026

   · 

  1 min read
• Press Releases

  Persica Pharmaceuticals publishes new analyses of antibiotic exposure-response, reinforcing the scientific case for PP353 in vertebrogenic Lumbar Back Pain

  September 4, 2026

   · 

  4 min read
• 

  Cancer

  AbbVie’s T cell engager delivers survival benefit in Phase 3 multiple myeloma study

  AbbVie’s etentamig has a relatively cleaner safety profile and an administration schedule that could give it an edge over other BCMA-targeting multiple myeloma therapies on the market, according to BMO Capital Markets.

  September 4, 2026

   · 

  2 min read

   · 

  Tristan Manalac
• Press Releases

  Immuron to launch PROIBS® in the United States

  September 4, 2026

   · 

  4 min read
• Press Releases

  GLP-1 Use Among Young Children With Obesity in US Remains Rare but Is Rising Rapidly

  September 4, 2026

   · 

  5 min read